Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.5000
+0.0400 (8.70%)
May 26, 2026, 4:00 PM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $20.39 million as of May 27, 2026. Its market cap has decreased by -53.61% in one year.
Market Cap
20.39M
Enterprise Value
11.35M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.50
Market Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 20.39M, a decrease of -87.66%. That is a compound annual growth rate of -33.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 18.76M | -54.79% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 27.32M |
| Oncotelic Therapeutics | 25.74M |
| Arch Biopartners | 21.74M |
| ZIVO Bioscience | 16.42M |
| Galera Therapeutics | 16.06M |
| Zeo ScientifiX | 15.40M |
| EOM Pharmaceuticals Holdings | 14.55M |
| HOOKIPA Pharma | 14.47M |